A multiancestral genome-wide exome array study of Alzheimer Disease, frontotemporal dementia, and progressive supranuclear palsy

JAMA Neurology

Volumn 72, Issue 4, 2015, Pages 414-422

  Chen, Jason A ^a   Wang, Qing ^a   Davis Turak, Jeremy ^a   Li, Yun ^a   Karydas, Anna M ^b   Hsu, Sandy C ^a   Sears, Renee L ^a   Chatzopoulou, Doxa ^a   Huang, Alden Y ^a   Wojta, Kevin J ^a   Klein, Eric ^a   Lee, Jason ^a   Beekly, Duane L ^c   Boxer, Adam ^b   Faber, Kelley M ^d   Haase, Claudia M ^e   Miller, Josh ^f   Poon, Wayne W ^g   Rosen, Ami ^h   Rosen, Howard ^b   Sapozhnikova, Anna ⁱ   Shapira, Jill ^j   Varpetian, Arousiak ^k   Foroud, Tatiana M ^d   Levenson, Robert W ⁱ   Levey, Allan I ^h   Kukull, Walter A ^c   Mendez, Mario F ^j   Ringman, John ^j,l   Chui, Helena ^k   Cotman, Carl ^g   DeCarli, Charles ^m   Miller, Bruce L ^b   Geschwind, Daniel H ^a,j   Coppola, Giovanni ^a,j   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f the State University of New Jersey   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^l UNIVERSITY OF CALIFORNIA   (United States)

^m UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ABCA7 GENE; ADULT; AFRICAN AMERICAN; AGED; ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; ASIAN; BRAIN REGION; CEREBELLUM; COHORT ANALYSIS; CONTROLLED STUDY; DATA ANALYSIS; DYSF GENE; ETHNIC DIFFERENCE; EUROPEAN; EVIDENCE BASED MEDICINE; EXOME; FEMALE; FRONTOTEMPORAL DEMENTIA; GENE; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENE IDENTIFICATION; GENE LOCATION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC MARKER; GENETIC SUSCEPTIBILITY; GENOTYPE; HERITABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MICROARRAY KIT; NEUROPATHOLOGY; NONHUMAN; PAXIP1 GENE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; STATISTICAL ANALYSIS; TISSUE DISTRIBUTION; VERY ELDERLY; VISUAL CORTEX; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETIC VARIATION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; MIDDLE AGED; PROCEDURES; RISK;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; EXOME; FEMALE; FRONTOTEMPORAL DEMENTIA; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; RISK; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 84928152687     PISSN: 21686149     EISSN: 21686157     Source Type: Journal    
DOI: 10.1001/jamaneurol.2014.4040     Document Type: Article

References (38)

1. Lendon CL, Ashall F, Goate AM. Exploring the etiology of Alzheimer disease using molecular genetics. JAMA. 1997;277(10):825-831.
2. Pericak-Vance MA, Bebout JL, Gaskell PC Jr, et al. Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage. Am J Hum Genet. 1991;48(6):1034-1050.
3. Naj AC, Jun G, Beecham GW, et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet. 2011;43(5):436-441.
4. Hollingworth P, Harold D, Sims R, et al Alzheimer's Disease Neuroimaging Initiative; CHARGE Consortium; EADI1 Consortium. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet. 2011;43(5):429-435.
5. Lambert JC, Ibrahim-Verbaas CA, Harold D, et al; European Alzheimer's Disease Initiative (EADI); Genetic and Environmental Risk in Alzheimer's Disease; Alzheimer's Disease Genetic Consortium; Cohorts for Heart and Aging Research in Genomic Epidemiology. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet. 2013;45(12):1452-1458.
6. Coppola G, Chinnathambi S, Lee JJ, et al Alzheimer's Disease Genetics Consortium. Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. Hum Mol Genet. 2012;21(15):3500-3512.
7. Guerreiro R, Wojtas A, Bras J, et al Alzheimer Genetic Analysis Group. TREM2 variants in Alzheimer's disease. NEngl JMed. 2013;368(2):117-127.
8. Rademakers R, Neumann M, Mackenzie IR. Advances in understanding the molecular basis of frontotemporal dementia. Nat Rev Neurol. 2012;8(8):423-434.
9. Baker M, Litvan I, Houlden H, et al. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum Mol Genet. 1999;8(4):711-715.
10. Pittman AM, Myers AJ, Abou-Sleiman P, et al. Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration. J Med Genet. 2005;42(11):837-846.
11. Höglinger GU, Melhem NM, Dickson DW, et al PSP Genetics Study Group. Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat Genet. 2011;43(7):699-705.
12. Van Deerlin VM, Sleiman PMA, Martinez-Lage M, et al. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet. 2010;42(3):234-239.
13. Ferrari R, Hernandez DG, Nalls MA, et al. Frontotemporal dementia and its subtypes: a genome-wide association study. Lancet Neurol. 2014;13(7):686-699.
14. Lee SH, Harold D, Nyholt DR, et al ANZGene Consortium, International Endogene Consortium, the Genetic and Environmental Risk for Alzheimer's Disease (GERAD1) Consortium. Estimation and partitioning of polygenic variation captured by common SNPs for Alzheimer's disease, multiple sclerosis and endometriosis. Hum Mol Genet. 2013;22(4):832-841.
15. GatzM, Reynolds CA, Fratiglioni L, et al. Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry. 2006;63(2):168-174.
16. Huyghe JR, Jackson AU, Fogarty MP, et al. Exome array analysis identifies new loci and low-frequency variants influencing insulin processing and secretion. Nat Genet. 2013;45(2):197-201.
17. Wang H, St Julien KR, Stevenson DK, et al. A genome-wide association study (GWAS) for bronchopulmonary dysplasia. Pediatrics. 2013;132(2):290-297.
18. Peloso GM, Auer PL, Bis JC, et al; NHLBI GO Exome Sequencing Project. Association of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56,000 whites and blacks. Am J Hum Genet. 2014;94(2):223-232.
19. Holmen OL, Zhang H, ZhouW, et al. No large-effect low-frequency coding variation found formyocardial infarction. Hum Mol Genet. 2014;23(17):4721-4728.
20. Chung SJ, KimMJ, Kim J, et al. Exome array study did not identify novel variants in Alzheimer's disease. Neurobiol Aging. 2014;35(8):1958.e13-1958.e14.
21. Coppola G, Miller BL, Chui H, et al. Genetic investigation in frontotemporal dementia and Alzheimer's disease: the GIFT Study. Ann Neurol. 2007;62(suppl 11):S52. Abstract T-10. http://onlinelibrary.wiley.com/doi/10.1002/ana.v62:11%2B/issuetoc. Accessed December 19, 2014.
22. Li Y, Chen JA, Sears RL, et al. An epigenetic signature in peripheral blood associated with the haplotype on 17q21.31, a risk factor for neurodegenerative tauopathy. PLoS Genet. 2014;10(3):e1004211. doi:10.1371/journal.pgen.1004211.
23. Wu MC, Lee S, Cai T, Li Y, BoehnkeM, Lin X. Rare-variant association testing for sequencing data with the sequence kernel association test. Am J Hum Genet. 2011;89(1):82-93.
24. Zhang B, Gaiteri C, Bodea LG, et al. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease. Cell. 2013;153(3):707-720.
25. Webster JA, Gibbs JR, Clarke J, et al NACC-Neuropathology Group. Genetic control of human brain transcript expression in Alzheimer disease. Am J Hum Genet. 2009;84(4):445-458.
26. Galvin JE, Palamand D, Strider J, Milone M, Pestronk A. The muscle protein dysferlin accumulates in the Alzheimer brain. Acta Neuropathol. 2006;112(6):665-671.
27. Rademakers R, Cruts M, Sleegers K, et al. Linkage and association studies identify a novel locus for Alzheimer disease at 7q36 in a Dutch population-based sample. Am J Hum Genet. 2005;77(4):643-652.
28. Stenson PD, MortM, Ball EV, Shaw K, Phillips A, Cooper DN. The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum Genet. 2014;133(1):1-9.
29. Reitz C, Jun G, Naj A, et al Alzheimer Disease Genetics Consortium. Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ε4,and the risk of late-onset Alzheimer disease in African Americans. JAMA. 2013;309(14):1483-1492.
30. Liu J, Aoki M, Illa I, et al. Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet. 1998;20(1):31-36.
31. Bashir R, Britton S, Strachan T, et al. A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B. Nat Genet. 1998;20(1):37-42.
32. Bansal D, Miyake K, Vogel SS, et al. Defective membrane repair in dysferlin-deficient muscular dystrophy. Nature. 2003;423(6936):168-172.
33. Han R, Campbell KP. Dysferlin and muscle membrane repair. Curr Opin Cell Biol. 2007;19(4):409-416.
34. Hochmeister S, Grundtner R, Bauer J, et al. Dysferlin is a new marker for leaky brain blood vessels in multiple sclerosis. J Neuropathol Exp Neurol. 2006;65(9):855-865.
35. Cacciottolo M, Nogalska A, D'Agostino C, Engel WK, Askanas V. Dysferlin is a newly identified binding partner of AßPP and it co-aggregates with amyloid-β42 within sporadic inclusion-body myositis (s-IBM) muscle fibers. Acta Neuropathol. 2013;126(5):781-783.
36. Jowsey PA, Doherty AJ, Rouse J. Human PTIP facilitates ATM-mediated activation of p53 and promotes cellular resistance to ionizing radiation. J Biol Chem. 2004;279(53):55562-55569.
37. Munoz IM, Jowsey PA, Toth R, Rouse J. Phospho-epitope binding by the BRCT domains of hPTIP controls multiple aspects of the cellular response to DNA damage. Nucleic Acids Res. 2007;35(16):5312-5322.
38. Wu J, PrindleMJ, Dressler GR, Yu X. PTIP regulates 53BP1 and SMC1 at the DNA damage sites. J Biol Chem. 2009;284(27):18078-18084.